Skip to main content

Table 1 Baseline characteristics of study participants in this study

From: Association of mitochondrial respiratory chain enzymes with the risk and mortality of sepsis among Chinese children

Characteristics

Deceased

Survived

P

Age, months

26 ± 37.13

27.32 ± 35.23

0.835

Male, n (%)

11 (68.8%)

25 (73.5%)

0.726

SOFA, n (%)

  

0.047

 0 to 10

3 (18.8%)

19 (55.9%)

 

 10 to 20

11 (68.8%)

13 (38.2%)

 

 > 20

2 (12.5%)

2 (5.9%)

 

PCIS, n (%)

  

0.005

 80 to 100

2 (12.5%)

19 (55.9%)

 

 71 to 80

4 (25%)

8 (23.5%)

 

 0 to 70

10 (62.5%)

7 (20.6%)

 

MODS > 4 Organs, n (%)

14 (87.5%)

14 (41.2%)

0.002

MOF > 3 Organs, n (%)

11 (68.8%)

9 (26.5%)

0.004

DIC, n (%)

14 (87.5%)

22 (64.7%)

0.094

Shock, n (%)

13 (81.3%)

23 (67.6%)

0.318

ARDS, n (%)

12 (75%)

19 (55.9%)

0.194

Brain Failure, n (%)

14 (87.5%)

21 (61.8%)

0.064

Respiratory Failure, n (%)

13 (81.3%)

26 (76.5%)

0.704

Heart Failure, n (%)

11 (68.8%)

8 (23.5%)

0.002

Liver Failure, n (%)

12 (75%)

6 (17.6%)

 < 0.001

Kidney Failure, n (%)

6 (37.5%)

5 (14.7%)

0.07

Stomach Failure, n (%)

12 (75%)

14 (41.2%)

0.026

Pancreas Failure, n (%)

3 (18.8%)

1 (2.9%)

0.055

Metabolic Acidosis, n (%)

12 (75%)

16 (47.1%)

0.063

Th1 cell (n/μl)

4.2 (1.9 to 6.5)

2.3 (1.9 to 2.6)

0.308

Th2 cell (n/μl)

0.3 (0.1 to 0.6)

0.1 (0.1 to 0.2)

0.075

CD3 (n/μl)

60 (53 to 71)

60 (40 to 73)

0.721

CD4 (n/μl)

32.5 (22 to 44)

23 (17 to 41)

0.251

CD8 (n/μl)

21.5 (17 to 27)

23 (18 to 33)

0.818

CD4/CD8

1.55 (0.87 to 2.19)

1 (0.68 to 1.5)

0.284

CD19 (n/μl)

27.4 (24.4 to 41)

28 (9 to 46)

0.858

CD16/CD56

6.5 (3 to 13)

9 (3 to 22)

0.294

IgG (g/L)

8.86 (6.46 to 13.76)

14.47 (10.26 to 23.61)

0.039

IgA (g/L)

0.8 (0.31 to 1.28)

0.36 (0.19 to 0.81)

0.260

IgM (g/L)

0.84 (0.53 to 1.09)

0.53 (0.35 to 0.76)

0.061

TRIG (mmol/L)

1.51 (0.97 to 2.39)

2.22 (1.5 to 2.69)

0.105

HDL (mmol/L)

0.81 (0.59 to 1.03)

0.69 (0.41 to 0.96)

0.173

LDL (mmol/L)

2.21 (1.63 to 2.79)

3.1 (2.17 to 3.79)

0.038

ALT (U/L)

28 (17.45 to 68.55)

168.5 (37.3 to 181.1)

0.003

AST (U/L)

50.15 (30.95 to 121.9)

104.1 (65.45 to 188.2)

0.105

LD (U/L)

320 (260 to 828)

874 (660 to 1089)

0.016

HBDH (U/L)

293.5 (199 to 741)

539 (413 to 749)

0.118

CK (U/L)

44.5 (32 to 77.5)

59 (20 to 142)

0.836

CKMB (ng/mL)

18 (12 to 27)

23.5 (18 to 38)

0.075

Glucose (mmol/L)

5.61 (4.81 to 6.74)

5.6 (3.2 to 8.15)

0.639

Ca (mmol/L)

2.26 (2.08 to 2.35)

1.96 (1.81 to 2.28)

0.015

WBC (10^9/L)

12.9 (8.14 to 16.65)

11.8 (7.02 to 16.96)

0.920

CRP (mg/mL)

8 (2 to 54)

23 (15 to 34)

0.116

PCT (ng/mL)

1.38 (0.27 to 2.55)

1.7 (0.1 to 2.89)

0.958

  1. P values are calculated by nonparametric Wilcoxon rank sum tests for continuous variables expressed as median (interquartile range) and χ2 tests for categorical variables expressed as count and percent
  2. SOFA Sequential organ failure score, PCIS Pediatric critical illness score, MODS Multiple organ dysfunction syndrome, MOF Multiple organ failure, DIC Disseminated intravascular coagulation, ARDS Acute respiratory distress syndrome, TRIG Triglyceride, HDL High-density lipoprotein, LDL Low density lipoprotein, ALT Alanine transaminase, AST Aspartate aminotransferase, LD Lactate dehydrogenase, HBDH Hydroxybutyrate dehydrogenase, CK Creatine Kinase, CKMB Creatine phosphokinase-Mb, WBC White blood cell, CRP C-Reactive Protein, PCT Procalcitonin
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us